United States Oncology Drugs Market Report 2017

Name: United States Oncology Drugs Market Report 2017
Brand: QYResearch
SKU: U0614EA7A23EN
Price: 3800 USD
Availability: InStock

September 2017 | 101 pages | ID: U0614EA7A23EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Oncology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Oncology Drugs in these regions, from 2012 to 2022 (forecast).

United States Oncology Drugs market competition by top manufacturers/players, with Oncology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Novartis A.G
Laboratrio Cristlia
Medley Genomics
F. Hoffmann-La Roche Ltd
Icon Plc.
Sanofi S.A.
Laboratoires Pierre Fabre
Eurofarma Laboratrios S.A.
Ach Laboratrios Farmacuticos S.A.
Laboratorios IMA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Oral Therapy
Injectable Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oncology Drugs for each application, including

Targeted Therapy
Chemotherapy
Hormonal Therapy
Biologic Therapy

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Oncology Drugs Market Report 2017

1 ONCOLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Oncology Drugs
1.2 Classification of Oncology Drugs by Product Category
  1.2.1 United States Oncology Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Oncology Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral Therapy
  1.2.4 Injectable Therapy
1.3 United States Oncology Drugs Market by Application/End Users
  1.3.1 United States Oncology Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Targeted Therapy
  1.3.3 Chemotherapy
  1.3.4 Hormonal Therapy
  1.3.5 Biologic Therapy
1.4 United States Oncology Drugs Market by Region
  1.4.1 United States Oncology Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Oncology Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Oncology Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Oncology Drugs Status and Prospect (2012-2022)
  1.4.5 New England Oncology Drugs Status and Prospect (2012-2022)
  1.4.6 The South Oncology Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Oncology Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oncology Drugs (2012-2022)
  1.5.1 United States Oncology Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Oncology Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ONCOLOGY DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oncology Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oncology Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oncology Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Oncology Drugs Market Competitive Situation and Trends
  2.4.1 United States Oncology Drugs Market Concentration Rate
  2.4.2 United States Oncology Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oncology Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ONCOLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Oncology Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Oncology Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Oncology Drugs Price by Region (2012-2017)

4 UNITED STATES ONCOLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Oncology Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oncology Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Oncology Drugs Price by Type (2012-2017)
4.4 United States Oncology Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ONCOLOGY DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oncology Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Oncology Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ONCOLOGY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis A.G
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oncology Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis A.G Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Laboratrio Cristlia
  6.2.2 Oncology Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Laboratrio Cristlia Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Medley Genomics
  6.3.2 Oncology Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Medley Genomics Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche Ltd
  6.4.2 Oncology Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F. Hoffmann-La Roche Ltd Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Icon Plc.
  6.5.2 Oncology Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Icon Plc. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi S.A.
  6.6.2 Oncology Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Laboratoires Pierre Fabre
  6.7.2 Oncology Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Laboratoires Pierre Fabre Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eurofarma Laboratrios S.A.
  6.8.2 Oncology Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eurofarma Laboratrios S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Ach Laboratrios Farmacuticos S.A.
  6.9.2 Oncology Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Laboratorios IMA
  6.10.2 Oncology Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Laboratorios IMA Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ONCOLOGY DRUGS MANUFACTURING COST ANALYSIS

7.1 Oncology Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oncology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ONCOLOGY DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Oncology Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oncology Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Oncology Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Oncology Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology Drugs
Figure United States Oncology Drugs Market Size (MT) by Type (2012-2022)
Figure United States Oncology Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Therapy Product Picture
Figure Injectable Therapy Product Picture
Figure United States Oncology Drugs Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Oncology Drugs by Application in 2016
Figure Targeted Therapy Examples
Table Key Downstream Customer in Targeted Therapy
Figure Chemotherapy Examples
Table Key Downstream Customer in Chemotherapy
Figure Hormonal Therapy Examples
Table Key Downstream Customer in Hormonal Therapy
Figure Biologic Therapy Examples
Table Key Downstream Customer in Biologic Therapy
Figure United States Oncology Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oncology Drugs Sales (MT) and Growth Rate (2012-2022)
Figure United States Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oncology Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Oncology Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Oncology Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oncology Drugs Sales Share by Players/Suppliers
Figure 2017 United States Oncology Drugs Sales Share by Players/Suppliers
Figure United States Oncology Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oncology Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oncology Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oncology Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Oncology Drugs Revenue Share by Players/Suppliers
Table United States Market Oncology Drugs Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Oncology Drugs Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Oncology Drugs Market Share of Top 3 Players/Suppliers
Figure United States Oncology Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oncology Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oncology Drugs Product Category
Table United States Oncology Drugs Sales (MT) by Region (2012-2017)
Table United States Oncology Drugs Sales Share by Region (2012-2017)
Figure United States Oncology Drugs Sales Share by Region (2012-2017)
Figure United States Oncology Drugs Sales Market Share by Region in 2016
Table United States Oncology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oncology Drugs Revenue Share by Region (2012-2017)
Figure United States Oncology Drugs Revenue Market Share by Region (2012-2017)
Figure United States Oncology Drugs Revenue Market Share by Region in 2016
Table United States Oncology Drugs Price (USD/Kg) by Region (2012-2017)
Table United States Oncology Drugs Sales (MT) by Type (2012-2017)
Table United States Oncology Drugs Sales Share by Type (2012-2017)
Figure United States Oncology Drugs Sales Share by Type (2012-2017)
Figure United States Oncology Drugs Sales Market Share by Type in 2016
Table United States Oncology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oncology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Drugs by Type (2012-2017)
Figure Revenue Market Share of Oncology Drugs by Type in 2016
Table United States Oncology Drugs Price (USD/Kg) by Types (2012-2017)
Figure United States Oncology Drugs Sales Growth Rate by Type (2012-2017)
Table United States Oncology Drugs Sales (MT) by Application (2012-2017)
Table United States Oncology Drugs Sales Market Share by Application (2012-2017)
Figure United States Oncology Drugs Sales Market Share by Application (2012-2017)
Figure United States Oncology Drugs Sales Market Share by Application in 2016
Table United States Oncology Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Oncology Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis A.G Basic Information List
Table Novartis A.G Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis A.G Oncology Drugs Sales Growth Rate (2012-2017)
Figure Novartis A.G Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Novartis A.G Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Laboratrio Cristlia Basic Information List
Table Laboratrio Cristlia Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Sales Growth Rate (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Medley Genomics Basic Information List
Table Medley Genomics Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Medley Genomics Oncology Drugs Sales Growth Rate (2012-2017)
Figure Medley Genomics Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Medley Genomics Oncology Drugs Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Icon Plc. Basic Information List
Table Icon Plc. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Icon Plc. Oncology Drugs Sales Growth Rate (2012-2017)
Figure Icon Plc. Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Icon Plc. Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Oncology Drugs Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Laboratoires Pierre Fabre Basic Information List
Table Laboratoires Pierre Fabre Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Sales Growth Rate (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Eurofarma Laboratrios S.A. Basic Information List
Table Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales Growth Rate (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Ach Laboratrios Farmacuticos S.A. Basic Information List
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales Growth Rate (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Laboratorios IMA Basic Information List
Table Laboratorios IMA Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratorios IMA Oncology Drugs Sales Growth Rate (2012-2017)
Figure Laboratorios IMA Oncology Drugs Sales Market Share in United States (2012-2017)
Figure Laboratorios IMA Oncology Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Drugs
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology Drugs Major Players/Suppliers in 2016
Table Major Buyers of Oncology Drugs
Table Distributors/Traders List
Figure United States Oncology Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oncology Drugs Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Oncology Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Oncology Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Oncology Drugs Sales Volume (MT) Forecast by Type in 2022
Table United States Oncology Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Oncology Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Oncology Drugs Sales Volume (MT) Forecast by Application in 2022
Table United States Oncology Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Oncology Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oncology Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oncology Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Oncology Drugs Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports